(Q44516630)

3 December 2017

Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases (English)

1 reference

3 December 2017

Listeria monocytogenes

0 references

author name string

Glück T

1

1 reference

3 December 2017

Linde HJ

2

1 reference

3 December 2017

Schölmerich J

3

1 reference

3 December 2017

Müller-Ladner U

4

1 reference

3 December 2017

Fiehn C

5

1 reference

3 December 2017

Bohland P

6

1 reference

3 December 2017

1 August 2002

1 reference

3 December 2017

Arthritis & Rheumatology

1 reference

3 December 2017

46

1 reference

3 December 2017

8

1 reference

3 December 2017

2255-7; author reply 2257

1 reference

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

3 December 2017

1 reference

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

Infliximab: a review of its use in the management of rheumatoid arthritis

21 January 2018

1 reference

Does administration of infliximab increase susceptibility to listeriosis?

21 January 2018

1 reference

Listeria arthritis in chronic polyarthritis during low dose prednisolone and methotrexate therapy. Case report and review of the literature

21 January 2018

1 reference

High incidence of Listeria monocytogenes in European red smear cheese.

21 January 2018

1 reference

Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.10374

1 reference

3 December 2017

1 reference